| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 746513 | 5-Triazol-2-yl-methyl-2-[2?,(2??-chlorophenyl)-thiazolidin-4?-one-3?-yl]-1,3,4-oxadiazole | 0.0462077035966088 | 0.4210504 |
| NSC 748404 | Null | 0.0462077035966088 | 0.57498762 |
| NSC 757002 | 5-chloro-1-(7-chloro-3-methyl-1,4-dioxyquinoxalin-2-yl)-5-(3,4,5-trimethoxy)-penta-2,4-dien-1-one | 0.0462077035966088 | 0.53079444 |
| NSC 102627 | Yoshi 864 | 0.0467178916101838 | 0.19389548 |
| NSC 115980 | Null | 0.0467178916101838 | 0.33589129 |
| NSC 123139 | L-Cysteine, S-[(4-methylphenyl)diphenylmethyl]- (9CI) | 0.0467178916101838 | 0.20621582 |
| NSC 139021 | 1-(2-Thiazolylazo)-2-naphthol | 0.0467178916101838 | 0.46590228 |
| NSC 212509 | Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) | 0.0467178916101838 | 0.39765978 |
| NSC 302325 | 2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- | 0.0467178916101838 | 0.46129863 |
| NSC 3091 | Ammonium, [.alpha.-[p-(dimethylamino)phenyl]-.alpha.-[4-(dimethyliminio)-2,5-cyclohexadien-1-ylidene]-p-tolyl]ethyldimethyl-, bromide, chloride (8CI) | 0.0467178916101838 | 0.26889439 |